Prevention, detection, evaluation, and management of high blood pressure in adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline

Annals of Internal Medicine

Volumn 168, Issue 5, 2018, Pages 351-358

  Carey, Robert M ^a   Whelton, Paul K ^b   Aronow, Wilbert S ^c   Casey, Donald E ^c   Collins, Karen J ^c   Himmelfarb, Cheryl Dennison ^c   DePalma, Sondra M ^c   Gidding, Sammuel ^c   Jamerson, Kenneth A ^c   Jones, Daniel W ^c   McLaughlin, Eric J ^c   Muntner, Paul ^c   Ovbiagele, Bruce ^c   Smith, Sidney C ^c   Spencer, Crystal C ^c   Stafford, Randall S ^c   Taler, Sandra J ^c   Thomas, Randall J ^c   Williams, Kim A ^c   Williamson, Jeff D ^c   Wright, Jackson T ^c   more..

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b TULANE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOLOGY; CARDIOVASCULAR RISK; CLASSIFICATION; DIAGNOSIS; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING; COMORBIDITY; MASS SCREENING; PROCEDURES; SECONDARY PREVENTION;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; COMORBIDITY; HUMANS; HYPERTENSION; MASS SCREENING; SECONDARY PREVENTION;

EID: 85042470778     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-3203     Document Type: Review

References (21)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60. [PMID: 23245609] doi:10.1016/S0140-6736(12)61766-8
2. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317:165-82. PMID: 28097354 doi:10.1001/jama.2016.19043
3. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058. [PMID: 19399161] doi:10.1371/journal.pmed.1000058
4. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. [PMID: 29133356] doi:10.1161/HYp.0000000000000065
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. [PMID: 14656957]
6. Gibbons GH, Harold JG, Jessup M, Robertson RM, Oetgen WJ. The next steps in developing clinical practice guidelines for prevention. Circulation. 2013;128:1716-7. PMID: 23929910 doi:10.1161/CIRCULATIONAHA.113.005548
7. Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. [PMID: 29133355] doi:10.1161/HYp.0000000000000067
8. Jacobs AK, Anderson JL, Halperin JL, Anderson JL, Halperin JL, Albert NM, et al; ACC/AHA Task Force Members. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130: 1208-17. [PMID: 25092464] doi:10.1161/CIR.0000000000000090
9. Thomopolous C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs less intensive blood pressure lowering and different achieved blood pressure levels-updated overview and meta-analysis of randomized trials. J Hypertens. 2016;34:613-22.
10. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435-43. [PMID: 26559744] doi:10.1016/S0140-6736(15)00805-3
11. Verdecchia P, Angeli F, Gentile G, Reboldi G. More versus less intensive blood pressure-lowering strategy: cumulative evidence and trial sequential analysis. Hypertension. 2016;68:642-53. PMID: 27456518 doi:10.1161/HYPERTENSIONAHA.116.07608
12. Bangalore S, Toklu B, Gianos E, Schwartzbard A, Weintraub H, Ogedegbe G, et al. Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials. Am J Med. 2017;130:707-19. PMID: 28109971 doi:10.1016/j.amjmed.2017.01.004
13. Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2:775-81. [PMID: 28564682] doi:10.1001/jamacardio.2017.1421
14. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT Jr, et al. Potential U.S. population impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline. Circulation. 2017. [PMID: 29133599] doi:10.1161/CIRCULATIONAHA.117.032582
15. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-73. [PMID: 24222018] doi:10.1161/01.cir.0000437741.48606.98
16. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362:1575-85. PMID: 20228401 doi:10.1056/NEJMoa1001286
17. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373:2103-16. PMID: 26551272 doi:10.1056/NEJMoa1511939
18. Perkovic V, Rodgers A. Redefining blood-pressure targets-SPRINT starts the marathon [Editorial]. N Engl J Med. 2015;373: 2175-8. [PMID: 26551394] doi:10.1056/NEJMe1513301
19. Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, et al; SPRINT Research Group. Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial. Diabetes Care. 2017. [PMID: 28793997] doi:10.2337/dc17-0885
20. Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78. PMID: 25880068 doi:10.1186/s12916-015-0328-1
21. Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, et al. Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension. Hypertension. 2016;68:297-306. PMID: 27296995 doi:10.1161/HYPERTENSIONAHA.116.07464